Feedback / Questions
Pusintin (bevacizumab biosimilar) - TOT Biopharm
https://www.pharmiweb.com/press-release/2021-03-24/tot-biopharm-announces-a-number-of-key-anti-tumor-drugs-have-entered-the-pivotal-clinical-stage-in-2020
Mar 24, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next